Cargando…
Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin’s lymphomas
Autores principales: | Marchesi, Francesco, Pimpinelli, Fulvia, Giannarelli, Diana, Ronchetti, Livia, Papa, Elena, Falcucci, Paolo, Pontone, Martina, Di Domenico, Enea Gino, di Martino, Simona, Laquintana, Valentina, Mandoj, Chiara, Conti, Laura, Cordone, Iole, La Malfa, Antonia, Viggiani, Caterina, Renzi, Daniela, Palombi, Francesca, Romano, Atelda, Pisani, Francesco, Gumenyuk, Svitlana, Di Bella, Ornella, Vujovic, Branka, Morrone, Aldo, Ciliberto, Gennaro, Ensoli, Fabrizio, Mengarelli, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451738/ https://www.ncbi.nlm.nih.gov/pubmed/34545184 http://dx.doi.org/10.1038/s41375-021-01418-8 |
Ejemplares similares
-
Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution
por: Pimpinelli, Fulvia, et al.
Publicado: (2021) -
Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia
por: Pimpinelli, Fulvia, et al.
Publicado: (2021) -
PB2416: EFFICACY AND SAFETY OF BIOSIMILAR PEGFILGRASTIM AFTER AUTOLOGOUS STEM CELL TRANSPLANT: A COMPARATIVE STUDY WITH BIOSIMILAR FILGRASTIM, LENOGRASTIM AND ORIGINATOR PEGFILGRASTIM
por: Marchesi, Francesco, et al.
Publicado: (2023) -
Association between CMV and Invasive Fungal Infections After Autologous Stem Cell Transplant in Lymphoproliferative Malignancies: Opportunistic Partnership or Cause-Effect Relationship?
por: Marchesi, Francesco, et al.
Publicado: (2019) -
Antibody Persistence 6 Months Post-Vaccination with BNT162b2 among Health Care Workers
por: Campo, Flaminia, et al.
Publicado: (2021)